Oxytocin and Vasopressin Are Related but Distinct Peptide Systems

Magnocellular neurons synthesize the precursors, process and package them with neurophysins, transport vesicles along axons, and release peptides from posterior-pituitary terminals in response to neural activity. Central dendritic or axonal release can follow different dynamics from peripheral blood release. A circulating assay therefore does not automatically quantify peptide action in a specific brain circuit.

Oxytocin primarily signals through OXTR, while vasopressin acts through AVPR1A, AVPR1B, and AVPR2, all GPCRs with tissue-specific coupling. At sufficient concentrations, ligands can activate related receptors, complicating pharmacological experiments. Selectivity should be demonstrated at relevant receptor expression and concentrations. An observed effect cannot be assigned to a named peptide solely because that peptide was measured nearby.

Both systems have been studied in social, stress, reproductive, cardiovascular, and fluid-balance contexts. Effects vary by circuit, species, sex, state, timing, receptor, and experimental design. Labels such as 'bonding hormone' or 'social peptide' erase this conditional biology. This comparison provides no claim about personality, relationships, treatment, administration, or individual response.

Behavioral studies also differ in whether they manipulate ligand, receptor, cell population, or environment. Those interventions do not answer the same causal question, and replication in one task or species cannot be generalized into a stable human trait label.